Johnson & Johnson

US · JNJ #19 by market cap Listed 1970 Quant Rating C 56

275.23 -3.20 -1.15%

Live - 104 symbols - heartbeat 35s ago · 2026-09-04 19:59

Pre-market 275.00 -1.23%

After-hours 276.53 +0.47%

Overnight 278.74 +0.11%

Market cap: 663.28B
P/E (TTM): 31.93
P/B: 7.81
EPS: 11.03
Div yield: 1.90%
52W pos: 95%

About Johnson & Johnson

Johnson & Johnson is a healthcare holding company split into two segments since spinning off its consumer-health business: Innovative Medicine, covering immunology, oncology, neuroscience, cardiovascular and pulmonary disease, and MedTech, which makes devices for surgery, orthopaedics, vision and other interventional care. Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson Sr. founded the company in New Brunswick, New Jersey, in 1887, where it remains based.

Founded: 1887
CEO: Mr. Joaquin Duato
Employees: 138,200
Headquarters: New Brunswick, New Jersey, United States of America
Fiscal year end: 12-27
Website: jnj.com

View SEC filings on EDGAR ›

Company profile

Exchange: US
Symbol: JNJ
Market-cap rank: #19
Listing date: 1970-01-01
Market cap: 663.28B
Float cap: 662.20B
Shares out: 2.41B
Float shares: 2.41B

Sectors & themes

Drug Manufacturers - General CAR-T Therapy Infectious Disease Government Pension Fund of Norway Global medical industry Regular Savings Plan Fractional Shares JP Star Stocks

Browse all sectors & themes

Quote time 2026-09-04 19:59:32

For reference only, not investment advice.